Pharmos (PARS) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Pharmos (PARS)

An SI Board Since October 1998

Posts	SubjectMarks	Bans	Symbol
1386	42	0	PARS

Emcee: Dr. John M. de Castro	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
986	Yosi you are better informed. I agree with your analysis of HU-211 and the FDA	Gabe Fernandez	-	2/3/2000
985	Pharmos Announces Record Quarterly Revenues in 1999 Fourth Quarter; Product Sal	Hope	-	1/27/2000
984	The way I see it. The study will be done. The clinical results will be there. a	yosi s	-	1/26/2000
983	check this out, lots more room to run globes.co.il	leigh aulper	-	1/26/2000
982	Rick I feel the FDA can be made to change .If HU-211 is as effective in control	Gabe Fernandez	-	1/26/2000
981	I understand your statement re FDA and do not mean to be preaching. I truly wo	Gabe Fernandez	-	1/26/2000
980	I, for one, admit that I have preached to the choir. I do, indeed, understand y	Rick Strange	-	1/26/2000
979	music to my ear High Tech Features "Pharmos' Value Could Be Upward	David Israel-Rosen	-	1/26/2000
978	You are preaching to the choir. If you read my post carefully, it discusses the	NeuroInvestment	-	1/26/2000
977	CONFUSED: What is the primary purpose of the study?. From a medical point of vi	Gabe Fernandez	-	1/26/2000
976	Thanks for the feedback. One wonders sometimes if the FDA is the gateway or the	Rick Strange	-	1/25/2000
975	1) It should. But given the character of the FDA CNS Division, which is very in	NeuroInvestment	-	1/25/2000
974	NeuroInvestment, Does the UCSC study (Marshal et al), showing ICP as the prime	Rick Strange	-	1/25/2000
973	Hi: Thanks for the clarification. It's an interesting period for Pars and u	arnie h	-	1/23/2000
972	There is a phase prior to unblinding, which is where the last cohort study is	NeuroInvestment	-	1/23/2000
971	Hi NI: My impression of unblinding is that the investigators learn who was tak	arnie h	-	1/22/2000
970	Pharmos is doing some of the planning and designing of a Phase 2-3, but at thi	NeuroInvestment	-	1/22/2000
969	All biotech are having a run. Pharmos guys spend a lot of time getting the stor	yosi s	-	1/22/2000
968	Yosi: I'd remind the thread we were told in the Annual meeting that the res	arnie h	-	1/21/2000
967	yosi sales for 4 qt are close to 2mm	David Israel-Rosen	-	1/20/2000
966	yosis s...thank you for the reply. The stock price surge is refreshing and thi	Ron	-	1/20/2000
965	Every one is buying. Taking all weak hands out on the way up. HU 211 works. pu	yosi s	-	1/20/2000
964	Hello Parsians, Any ideas on the recent run-up in the stock price? Is there a	Ron	-	1/20/2000
963	It is very nice to see Pharmos participating in the biotech rally. + news due	yosi s	-	1/4/2000
962	IMHO, the recent run-up is the results of the general positive sentiment toward	Dr. John M. de Castro	-	1/4/2000

Go to reply# or date (mm/dd/yy):